SINOMAB BIO-B 03681·

Gross margin ----------------100.00%------30.92%--26.80%4.11%---- Net margin -----------------1112.16%-------17810.33%---9138.25%8672.08%---- ROE 94.16%---305.08%399.23%---------42.37%---55.76%13.40%-82.25%26.48%-95.97%13.72%-20.67%75.30% ROA -32.11%---94.14%62.03%---------27.67%---28.18%0.51%-28.68%0.50%-24.58%4.09%-11.56%13.02% Revenue growth ----------------------------48.42%------ Attributable profit growth -----74.28%--------------1.40%--14.45%13.04%23.85%9.40%43.29%19.45% Debt-to-assets 131.52%--69.14%62.38%--------34.70%--49.46%14.77%65.13%15.67%74.38%9.25%44.07%30.31% Current ratio 0.69--1.771.08--------6.06--2.393.671.560.820.910.651.911.00 Operating cash flow / net profit 0.77--0.560.21--------0.51--1.060.550.550.510.710.160.670.04 Operating cash flow / revenue -----------------567.53%-------9805.64%---6456.12%3349.52%----

Attributable profit growth -----155.69%-- Debt-to-assets ----47.19%-- Current ratio ----1.35-- Operating cash flow / net profit 0.54--0.230.31

Revenue ----------------25.91M------1.36M--2.03M48.42%---- Other income and gains 3.41M--8.67M154.06%--------28.75M--55.12M91.70%10.75M80.50%7.62M29.08%29.27M284.08% Gross profit ----------------25.91M------422.00K--543.00K28.67%---- Administrative expenses 6.99M--9.00M28.66%--------133.40M--82.59M38.09%97.61M18.19%67.72M30.63%46.38M31.50% Net finance costs 2.96M--3.03M2.33%--------5.82M--4.96M14.76%6.58M32.69%8.66M31.55%5.53M36.20% Income tax 0--0------------------------------ Operating profit -----------------278.08M---273.80M1.54%-236.53M13.61%-176.48M25.39%-99.46M43.64% Share of associates and JVs -----------------4.29M---5.40M25.81%------------ Profit before tax -51.90M---83.61M61.10%---------288.19M---284.16M1.40%-243.11M14.45%-185.14M23.85%-104.98M43.29% Net profit -51.90M---83.61M61.10%---------288.19M---284.16M1.40%-243.11M14.45%-185.14M23.85%-104.98M43.29% Net profit attributable to owners -47.97M---83.61M74.28%---------288.19M---284.16M1.40%-243.11M14.45%-185.14M23.85%-104.98M43.29%

Other income and gains 9.80M--23.46M139.36% Administrative expenses 23.73M--39.01M64.37% Net finance costs 2.99M--3.31M10.80% Income tax 0--0-- Profit before tax -49.82M---127.39M155.69% Net profit -49.82M---127.39M155.69% Net profit attributable to owners -49.82M---127.39M155.69%

Cash and cash equivalents 66.10M--41.51M37.19%--------562.98M--345.71M38.59%203.66M41.09%61.90M69.61%322.71M421.34% Total current assets 126.83M--50.27M60.36%--------595.68M--447.09M24.94%270.18M39.57%185.34M31.40%389.90M110.37% Total assets 161.64M--88.82M45.05%--------1.04B--1.01B3.20%847.79M15.92%753.10M11.17%908.11M20.58% Total current liabilities 184.91M--28.42M84.63%--------98.36M--187.39M90.51%172.65M7.87%203.50M17.87%204.04M0.27% Total liabilities 212.59M--61.41M71.11%--------361.43M--498.77M38.00%552.20M10.71%560.19M1.45%400.23M28.55% Equity attributable to owners -50.95M--27.41M153.79%--------680.23M--509.57M25.09%295.58M41.99%192.91M34.74%507.88M163.27% Total equity -50.95M--27.41M153.79%--------680.23M--509.57M25.09%295.58M41.99%192.91M34.74%507.88M163.27%

Cash and cash equivalents ----151.78M-- Total current assets ----236.96M-- Total assets ----684.58M-- Total current liabilities ----174.89M-- Total liabilities ----323.06M-- Equity attributable to owners ----361.52M-- Total equity ----361.52M--

Net cash from operating activities -40.20M---46.83M16.49%---------147.06M---300.54M104.36%-133.85M55.46%-130.80M2.28%-70.48M46.12% Net cash from investing activities 10.31M--21.47M108.10%---------137.70M---81.36M40.92%-96.92M19.13%-94.48M2.52%16.25M117.20% Net cash from financing activities 89.03M---3.56M103.99%--------57.52M--102.28M77.84%82.27M19.57%73.27M10.94%329.39M349.57% Net change in cash 59.15M---28.92M148.89%---------227.25M---279.61M23.04%-148.50M46.89%-152.01M2.37%275.16M281.01%

Net cash from operating activities -26.91M---29.91M11.15% Net cash from investing activities 35.23M---37.05M205.15% Net cash from financing activities 38.26M---74.88M295.71% Net change in cash 46.59M---141.83M404.45%